Skip to content
Back to news

Spartners: Biotech start-up welcome to apply!

From 17 October, life sciences start-up with innovative concepts that address unmet medical needs are invited to apply to join the Servier and BioLabs incubator. Named Spartners, the incubator will be housed in the new Servier Research and Development Institute in Paris-Saclay, which will open in 2023.

Logo Spartners by Servier & BioLabs

Managed by BioLabs, developer and operator of high-end coworking labs in the United States and Europe, Spartners is a start-up incubator that is unique in France and aims to become a major player in therapeutic innovation. All the conditions are in place to stimulate research and promote knowledge sharing..

A tailor-made combination of space, services, and state-of-the-art equipment

Designed to accommodate about 15 start-ups, i.e. more than 100 scientists, Spartners’ 1,850 m2 building will combine shared and private laboratories with modular offices and flexible workstations specially designed to facilitate interaction. The work environment will be rounded out with meeting, reception, and dining areas.

“We want the space to not only be state-of-the-art in terms of facilities, laboratory equipment, and business services, but also to be an inspiring and energizing place. Spartners is both a place to stimulate innovation and a way of working based on interaction and collaboration.”

Olivier Nosjean, Director of Open Innovation at Servier

A rich and productive ecosystem to benefit patients

Spartners will provide unique opportunities for entrepreneurs to test, develop, and grow their ideas. They will be able to evolve autonomously, while simultaneously benefiting from Servier’s scientific and technological expertise. Residents will also be able to connect with other entrepreneurs and industry leaders from the Paris-Saclay ecosystem and around the world.

“Spartners is a reflection of Servier’s commitment to open innovation and its desire to bring together a variety of healthcare players to accelerate the discovery of therapeutic solutions to benefit patients. We are pleased to collaborate with BioLabs so that Spartners can be a place of synergy and innovation that will contribute to the dynamism of the healthcare ecosystem in France and Europe.”

Olivier Nosjean, Director of Open Innovation at Servier

The selection committee will be made up of representatives from Servier and BioLabs, as well as experts representing key players in healthcare innovation: Medicen, France Biotech, the SATT network (Technology Transfer Acceleration Companies), and Bpifrance. To find out more

Interested? The application form is available at https://www.biolabs.io/apply-online

Did you know?

In 2023, the Servier Paris-Saclay Research & Development Institute will open its doors within the Paris-Saclay interdisciplinary innovation cluster. In a few years, this scientific center of excellence will bring together nearly 25% of French scientific research.

Servier’s objective? To develop more agile, open, and increasingly patient-centric R&D to accelerate the discovery of innovative therapeutic solutions.

Coverage of the R&D Institute Paris-Saclay video

Discover the Servier Research and Development Institute at Paris-Saclay